WHO Ethiopia Successfully Completes Workshop of Biennium 2024-2025 Planning

The Ethiopian Country Office of the World Health Organization- (WCO Ethiopia) successfully completed a two-day planning workshop in consultation with government stakeholders and development partners.

Held from 12th – 13th December 2022, the planning workshop aimed at aligning with the WCO Country Cooperation Strategy (CCS) 2021-2025, the 13th General Program of Work (GPW 13), the Sustainable Development Goals (SDGs), the United Nations Sustainable Development Cooperation Framework (UNSDCF) and the National Health Sector Transformation Plan II of Ethiopia.

Creating better understanding on cross-cutting principles; rationalizing and prioritizing national strategies as well as avoiding duplication of efforts while creating synergy among partners were also the objectives of the workshop.

Opening the workshop WCO- Ethiopia Deputy Representative Dr. Dlamini Rose recalled how the COVID-19 pandemic demonstrated the fundamental importance of the global detection, response and coordination roles that only WHO can play across members states.
The previous biennium has revealed the need for strong credible and independent WHO on the world stage, Dr. Dlamini Said adding the planning for 2024 -2025 budget year is an opportunity to guide WHO’s contributions towards the end of the GPW 13 on 2025.

Deputy director of the Ethiopian Public Health Institute (EPHI) Aschalew Abayneh on his part said the government of Ethiopia is giving a due emphasis on Value for Money (VFM) Gender, Equity, Human Rights and Disability (GEHRD) and other dimensions of the cooperation strategy.
The planning exercise should take the dynamic realities of the country in to consideration and give due consideration to the conflict affected regions of Tigray, Amhara and Afar, the Deputy Director stated.

The director also appreciated the endeavor by WCO-Ethiopia to align the organizational plan with the national priorities and strategies.
The workshop has brought more than 50 participants from WCO the Federal Health sector and Developing Partners together.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Alzheimer's Concerns High; Aducanumab Knowledge Low thumbnail

Alzheimer’s Concerns High; Aducanumab Knowledge Low

Concerns about Alzheimer's disease were high, but knowledge about aducanumab (Aduhelm) was low, survey data found. Among 1,035 older Americans surveyed during a period when media coverage of the FDA's controversial approval of aducanumab was high, 84.9% said they were concerned about Alzheimer's disease, reported Julie Zissimopoulos, PhD, of University of Southern California in Los…
Read More
Encouraging Early Start for Novel Drug for Triple-Negative Breast Cancer thumbnail

Encouraging Early Start for Novel Drug for Triple-Negative Breast Cancer

An experimental drug that blocks nitric oxide signaling (NOS) achieved a high response rate in combination with chemotherapy in a preliminary clinical study of chemotherapy-resistant metastatic triple-negative breast cancer (TNBC). Overall, 46% of patients responded to the NOS inhibitor NG-monomethyl-L-arginine (L-NMMA) plus a taxane, including 82% of patients with locally advanced disease. Three patients with…
Read More
HIV: Dual Therapy With Twice-Yearly Injections on the Horizon thumbnail

HIV: Dual Therapy With Twice-Yearly Injections on the Horizon

One year into treatment with an every-6-month dose of the investigational drug lenacapavir (LEN, Gilead Sciences) in a dual-treatment combination, 88% of treatment-naive people living with HIV had undetectable viral loads. The findings, presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2022 Annual Meeting, also showed the drug was well tolerated, with 2…
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?

Total
0
Share